Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
about
Transfusion transmission of HCV, a long but successful road map to safetyCorrelates of spontaneous clearance of hepatitis C virus among people with hemophiliaEstimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionSero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west NigeriaDifferent HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, ChinaCo-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlatesPrevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia.A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsFactors associated with spontaneous clearance of hepatitis C virus in Chinese populationHepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.Donor Risk Index for African American liver transplant recipients with hepatitis C virus.The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, China.Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME)Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicatorsImpact of host responses on control of hepatitis C virus infection in Chinese blood donors.Role of IL28B for chronic hepatitis C treatment toward personalized medicine.Host genetic variants influencing the clinical course of hepatitis C virus infection.Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus.Confirmatory testing of hepatitis C virus-positive enzyme immunoassay results in limited-resource countries: should it be attempted?Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.Discovery of critical host factor, IL-28B, associated with response to hepatitis C virus treatment.Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome
P2860
Q26865471-ACDB8DD7-FBD7-4A7A-8456-2A631CD7ED8FQ27480307-7EC5ACF2-8798-4C68-AE3F-6177E6724C8FQ27485372-A6AFFE68-EBE2-4B91-A6B9-7278239FDD0CQ27490431-E954B4C7-143C-4D30-A623-868CD77DDFAAQ28485435-7ACCC402-1E86-455C-B685-D4FDD1F81C95Q33576933-5C0934E8-27F3-4A4E-9732-3BC721C82DEBQ33933656-28B352E4-8B59-43A8-B8C9-056F6B258047Q33999798-C53F5D70-4B50-4778-A736-D914D6210B0BQ34009690-1EEFF60E-CC42-4AC3-8B37-2C7C88D52987Q34101320-9039FB51-65C7-4A83-8C31-25FF206EBF4BQ36032616-9BD834E0-6158-41D8-BFCE-6E7C27B31E00Q36252455-75373822-8442-44C7-A462-5A84E8354A26Q36384812-354B8C2C-A188-4585-AF1A-1962071423B2Q36575228-2DE85407-3229-49A8-8192-0836F52591A2Q36580931-0F3D99BF-0BB4-49A0-A8D6-DF90AF6651F0Q36858883-8F072F22-1CD4-4895-A581-1100BC673A31Q36863802-C98C9E11-E2C2-429D-9D02-AC5518D822F9Q37062443-2745AC4A-AFA0-4220-9AB8-B2F07BB2D8D1Q37078196-DF687E35-EF08-453E-9E6C-59661DB56864Q38170161-C79CEBB2-A6C6-4589-8AC8-0898ED847ED6Q38554500-88BDEB2B-82D5-47F4-AAAB-F00A6B7862ECQ40329699-92B909D5-F11B-427E-9F50-EB261DF4E91DQ41724118-63216DBA-984F-4BE0-B2CF-14C389C72DC1Q42977416-7FF40D28-701B-42B5-8781-2557A6144B95Q43038306-B1E46554-BD29-4019-8420-F97B3FB41087Q43040505-1569B935-1192-46BD-9D4A-0520E14A1167Q43040840-B9255579-6479-43BB-A7AC-BFDEE55A0B55Q43047486-A05E93A0-B1C0-47E2-A711-7A2A3F89A049Q43537838-A8A4C5A4-0700-430B-9A73-197C7D76FBF3Q48081521-7425AB22-84AD-4856-AE0E-D3B235F73685Q50894834-5B647784-C60F-4103-84B3-E60536BA8BB5Q58701375-0D05B96A-F00A-4CAE-897F-4270402FDBF4
P2860
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
@en
Correlates of hepatitis C virus
@nl
type
label
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
@en
Correlates of hepatitis C virus
@nl
prefLabel
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
@en
Correlates of hepatitis C virus
@nl
P2093
P2860
P1433
P1476
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
@en
P2093
David J Wright
Edward L Murphy
Jennie Orland
NHLBI Retrovirus Epidemiology Donor Study (REDS) Group
Simone A Glynn
Steven Kleinman
P2860
P304
P356
10.1111/J.1537-2995.2006.00745.X
P577
2006-03-01T00:00:00Z